Imidazo[1,5-g][1,4]diazepines, TIBO analogues lacking the phenyl ring: Synthesis and evaluation as Anti-HIV agents

Tetrahedron

Volumn 52, Issue 48, 1996, Pages 15157-15170

  Janin, Yves L ^a   Aubertin, Anne Marie ^b   Chiaroni, Angèle ^a   Riche, Claude ^a   Monneret, Claude ^c   Bisagni, Emile ^d   Grierson, David S ^a  

^a INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^b INSERM   (France)

^c INSTITUT CURIE   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIAZEPINE DERIVATIVE; NEVIRAPINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG RESISTANCE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VITRO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0030602251     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(96)00952-0     Document Type: Article

References (61)

1. 1 Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kukla, M.J.; Breslin, H.J.; Raeymaeckers, A.; Van Gelder, J.; Woestenborghs, R.; Heykants, J.; Schellekens, K.; Janssen, M.A.C.; De Clercq, E.; Janssen, P.A. Nature 1990, 343, 470-474.
2. 2 Hargrave, K.D.; Proudfoot, J.R.; Grozinger, K.G.; Cullen, E.; Kapadia, S.R.; Patel, U.R.; Fuchs, V.U.; Mauldin, S.C.; Vitous, J.; Behnke, M.L.; Klunder, J.M.; Pal, K.; Skiles, J.W.; McNeill, D.W.; Rose, J.M.; Chow, G.C.; Skoog, M.T.; Wu, J.C.; Schmidt, G.; Engel, W.W.; Eberlein, W.G.; Saboe, T.D.; Campbell, S.J.; Rosenthal, A.S.; Adams, J. J. Med. Chem. 1991, 34, 2231-2241.
3. 3 Miyasaka, T.; Tanaka, H.; Baba, M.; Hayakawa, H.; Walker, R.T.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1989, 32, 2507-2509.
4. 4 Saari, W.S.; Wai, J.S.; Fisher, T.E.; Thomas, C.M.; Hoffman, J.M.; Rooney, C.S.; Smith, A.M.; Jones, J.H.; Bamberger, D.L.; Goldman, M.E.; O'Brien, J.A.; Nunberg, J.H.; Quintero, J.C.; Schleif, W.A.; Emini, E.A.; Anderson, P.S. J. Med. Chem. 1992, 35, 3792-3802.
5. 5 Romero, D.L.; Morge, R.A.; Biles, C.; Berrios-Pena, N.; May, P.D.; Palmer, J.R.; Johnson, P.D.; Smith, H.W.; Busso, M.; Tan, C.H.; Voorman, R.L.; Reuser, F.; Althaus, I.W.; Downey, K.M.; So, A.G.; Resnick, L.; Tarpley, W.G.; Aristoff, P.A. J. Med. Chem. 1994, 37, 999-1014; and references therein.
6. 6 Livermore, D.G.H.; Bethell, R.C.; Cammack, N.; Hancock, A.P.; Hann, M.M.; Green, D.V.S.; Lamont, R.B.; Noble, S.A.; Orr, D.C.; Payne, J.J.; Ramsay, MV.J.; Shingler, A.H.; Smith, C.; Storer, R.; Williamson, C; Willson, T. J. Med. Chem. 1993, 36, 3784-3794.
7. 7 Tucker, T.J.; Lyle, T.A.; Wiscount, C.M.; Britcher, S.F.; Young, S.D.; Sanders W.M.; Lumma, W.C.; Goldman, M.E.; O'Brien, J.A.; Ball, R.J.; Scheilf, W.A.; Emini, E.A.; Huff, J.R.; Anderson, P.S. J. Med. Chem. 1994, 37, 2437-2444.
8. 8 Massa, S.; Mai, A.; Artico, M.; Sbardella, G.; Tramontano, E.; Loi, A.G.; Scano, P.; La Colla, P. Antiviral Chem. Chemother. 1995, 6, 1-8.
9. 9 Williams, T.M.; Ciccarone, T.M.; MacTough, S.C.; Rooney, C.S.; Balani, S.K.; Condra, J.H.; Emini, E.A.; Goldman, M.E.; Greenlee, W.J.; Kaufman, L.R.; O'Brien, J.A.; Sardana, V.V.; Schleif, W.A.; Theoharides, A.D.; Anderson, P.S. J. Med. Chem. 1993, 36, 1291-1294.
10. 10 Pauwels, R.; Andries, K.; Debyser, Z.; Daele, P.V.; Schols, D.; Stoffels, P.; DeVreese K.; Woestenborghs, R.; Vandamme, A-M.; Janssen, C.G.M.; Anne, J.; Cauwenbergh, G.; Desmyter, J.; Heykants, J.; Janssen, M.; De Clercq, E.; Janssen, P.A. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1711-1715.
11. 11 De Clercq, E. Med. Res. Rev. 1993, 13, 229-258.
12. 12 Young, S.D. Perspectives in Drug Discovery and Design 1993, 1, 181-192.
13. 13 Nanni, R.G.; Ding, J.; Jacobo-Molina, A.; Hughes, S.H.; Arnold, E. Perspectives in Drug Discovery and Design 1993, 1, 129-150.
14. 14 Tantillo, C; Ding, J.; Jacobo-Molina, A.; Nanni, R.; Boyer, P.L.; Hughes, S.H.; Pauwels, R.; Andries, K.; Janssen, P.A.; Arnold, E. J. Mol. Biol. 1994, 243, 369-387.
15. 15 Kohlstaedt, L.A.; Wang, J.; Friedman, J.M.; Rice, P.A.; Steitz, T.A. Science 1992, 256, 1783-1790.
16. 16 Jacobo-Molina, A.; Ding, J.; Nanni, R.G.; Clark, A.D.; Lu, X.; Tantillo, C.; Williams, R.L.; Kamer, G.; Ferris, A.L.; Clark, P. Hizi, A.; Hughes, S.H.; Arnold, E. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6320-6324.
17. 17 Jager, J.; Smerdon, S.J.; Wang, J.; Boisvert, D.C.; Steitz, T.A. Structure, 1994, 2, 869-876.
18. 18 Smerdon, S.J.; Jäger, J.; Wang, J.; Kohlstaedt, L.A.; Chirino, A.J.; Friedman, J.M.; Rice, P.A.; Steitz, T.A. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3911-3915.
19. 19 Stammers, D.K.; Somers, D.O'N.; Ross, C.K.; Kirby, I.; Ray, P.H.; Wilson, J.E.; Normann, M.; Ren, J.S.; Esnouf, R.M.; Carman, E.F.; Jones, E.Y.; Stuart, D.I.; J. Mol. Biol. 1994, 242, 586-588.
20. 20 Cohen, K.A.; Hopkins, J.; Ingraham, R.H.; Pargellis, C.; Wu, J.C.; Palladino, D.E.H.; Kinkade, P.; Warren, T.C.; Rogers, S.; Adams, J.; Farina, P.R.; Grob, P.M. J. Biol. Chem. 1991, 266, 14670-14674.
21. 21 Wu, J.C.; Warren, T.C.; Adams, J.; Proudfoot, J.; Skiles, J.; Raghavan, P.; Perry, C.; Potocki, I.; Farina, P.R.; Grob, P.M. Biochemistry 1991, 30, 2022-2026.
22. 22 Saunders, J. Drug Des. Discovery 1992, 8, 255-263.
23. 23 Richman, D.D.; Havlir, D.; Corbeil, J.; Looney, D.; Ignacio, C.; Spector, S.A.; Sullivan, J.; Cheeseman, S.; Barringer, K.; Pauletti, D.; Shih, C.K.; Myers, M.; Griffin, L. J. Virol 1994, 68, 1660-1666.
24. 24 Mellors, J.W.; Im, G.J.; Tramontano, E.; Winkler, S.R.; Medina, D.J.; Dutschman, G.E.; Bazmi, H.Z.; Piras, G.; Gonzalez, C.J.; Cheng, Y C. Mol. Pharmacol. 1993, 43, 11-16.
25. 25 De Clercq, E. Biochem. Pharmacol. 1994, 47, 155-169.
26. 26 De Clercq, E. J. Med. Chem. 1995, 38, 2491-2517.
27. 27 Kukla, M.J.; Breslin, H.J.; Pauwels, R.; Fedde, C.L.; Miranda, M.; Scott, M.K.; Sherrill, R.G.; Raeymaeckers, A.; Gelder, J.; Andries, K.; Janssen, M.A.C.; De Clercq, E.; Janssen, P.A. J. Med. Chem. 1991, 34, 746-751.
28. 28 Kukla, M.J.; Breslin, H.J.; Diamond, C.J.; Grous, P.P.; Ho, C.Y.; Miranda, M.; Rodgers, J.D.; Sherrill, R.G.; De Clercq, E.; Pauwels, R.; Andries, K.; Moens, L.J.; Janssen, M.A.C.; Janssen, P.A. J. Med. Chem. 1991, 34, 3187-3197.
29. 29 Liu, J.; Dodd, R.H. J. Heterocyclic Chem. 1995, 32, 523-528.
30. 30 Breslin, H.J.; Kukla, M.J.; Ludovici, W.D.; Mohrbacher, R.; Ho, W.; Miranda, M.; Rodgers, J.D.; Hitchens, T.K.; Leo, G.; Gauthier, D.A.; Ho, C.Y.; Scott, M.K.; De Clercq, E.; Pauwels, R.; Andries, K.; Janssen, M.A.C.; Janssen, P.A. J. Med. Chem. 1995, 38, 771-793.
31. 31 Swayze, E.E.; Peiris, S.M.; Kucera, L.S.; White, E.L.; Wise, D.S.; Drach; J.C.; Townsend, L.B. Biorg. Med. Chem. Lett. 1993, 3, 543-546.
32. 32 Gardiner, J.M.; Loyns, C.R.; Burke, A.; Khan, A.; Mahmood, N. Biorg. Med. Chem. Lett. 1995, 5, 1251-1254.
33. 33 Bell, F.W.; Cantrell, A.S.; Högberg, M.; Jaskunas, S.R.; Johansson, N.G.; Jordan, C.L.; Kinnick, M.D.; Lind, P.; Morin, J.M.; Noréen, R.; Öberg, B.; Palkowitz, J.A.; Parrish, C.A.; Pranc, P.; Sahlberg, C.; Ternansky, R.J.; Vasileff, R.T.; Vrang, L.; West, S.J.; Zhang, H.; Zhou, X-X. J. Med. Chem. 1995, 38, 4929-4936.
34. 34 Salaski, E.J. Tetrahedron Lett. 1995, 36, 1387.
35. 35 Ho, W.; Kukla, M.J.; Breslin, H.J.; Ludovici, W.D.; Grous, P.P.; Diamond, C.J.; Miranda, M.; Rodgers, J.D.; Ho, C.Y.; De Clercq, E.; Pauwels, R.; Andries, K.; Janssen, M.A.C.; Janssen, P.A. J. Med. Chem. 1995, 38, 794-802.
36. 36 Ho, C.Y.; Kukla, M.J. Biorg. Med. Chem. Lett. 1991, 1(10), 531-534.
37. 37 Pauwels, R.; Andries, K.; Debyser, Z.; Kukla, M.J.; Schols, D.; Breslin, H.J.; Woestenborghs, R.; Desmyter, J.; Janssen, M.A.C.; De Clercq, E.; Janssen, P.A. Antimicrob. Agents Chemother. 1994, 38, 2863-2870.
38. 38 Richman, D.; Shih, C K.; Lowy, I.; Rose, J.; Prodanovich, P.; Gogg, S.; Griffin, J. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 11241-11245.
39. 39 Balzarini, J.; Karlsson, A.; Perez-Perez, M J.; Vrang, L.; Walbers, J.; Zhang, H.; Oeberg, B.; Vandamme, A M.; Camarasa, M J.; De Clercq, E. Virology 1992, 192, 246-253.
40. 40 Mellors, J.W.; Dutschman, O.E.; Im, G.J.; Tramontano, E.; Winkler, S.R.; Cheng, Y C. Mol. Pharmacol. 1992, 41, 446-451.
41. 41 Mui, P.W.; Jacober, S.P.; Hargrave, K.D.; Adams, J. J. Med. Chem. 1992, 35, 201-202.
42. 42 Cordi, A.A.; Snyers, M.P.; Giraud-Mangin, D.; Van der Maesen, C.; Van Hoeck, J.P.; Beuze, S.; Ellens, E.; Napora, F.; Gillet, C.; Gorissen, H.; Calderon, P.; Remacle, M.D.; Janssen de Varebeke, P.; Van Dorsser, W.; Roba, J. Eur. J. Med. Chem. 1990, 25, 557-568.
43. 43 Altman, J.; Wilchek, M. J. Heterocydic. Chem. 1988, 25, 915-916.
44. 44 Compernolle, F.; Ashty Saleh, M.; Toppet, S.; Hoomaert, G. J. Org. Chem. 1991, 56, 5192-5196.
45. 45 In contrast, addition of NaI to the reaction medium had no effect on reaction rate or product yield.
46. 46 Sammes, P.G.; Smith, S. J. Chem. Soc. Perkin I 1984, 2415-2419.
47. 47 Ross, S.D. J. Am. Chem. Soc., 1947, 69, 2982-2983.
48. 48 Huh, N.; Thompson, C.M. Tetrahedron, 1995, 21, 5935-5950.
49. 49 Rubialta, M.; Diez, A.; Vila, C. Tetrahedron 1990, 46, 4443-4456.
50. 50 Cink, R.D.; Forsyth, C.J. J. Org. Chem. 1995, 60, 8122-8123.
51. 51 Overberger, C.G.; Vorchheimer, N. J. Am. Chem. Soc. 1963, 85, 951-955.
52. 52 Minoura, Y.; Takebayashi, M.; Price, C.C. J. Am. Chem. Soc. 1959, 81, 4689-4692.
53. 53 Ding, J.; Das, K.; Moereels, H.; Koymans, L.; Andries, K.; Janssens, P.A.J.; Hughes, S.H.; Arnold, E. Stuctural Biology 1995, 2, 407-415.
54. 54 Ren, J.; Esnouf, R.; Hopkins, A.; Ross, C.; Jones, Y.; Stammers, D.; Stuart, D. Structure, 1995, 3, 915-926.
55. 55 Considerable differences exist between the solid state conformation adopted by TIBO with and without association with RT; see also: Liaw, Y.-C; Gao, Y.-G.; Robinson, H.; Wang, A. H.-J. J. Am. Chem. Soc. 1991, 113, 1857-1859.
56. 56 Schafer, W.; Freibe, W-G.; Leinert, H.; Mertens, A.; Poll, T.; von der Saal, W.; Zilch, H.; Nuber, B.; Ziegler, M.L. J. Med. Chem. 1993, 36, 726-732.
57. 57 Moog, C.; Wick, A.; Le Ber, P.; Kim, A.; Aubertin, A.M. Antiviral Research 1994, 24, 275-288.
58. 58 Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.
59. 50, synergism, antagonism, low-dose risk, receptor binding and enzyme kinetics. Computer software for Apple II Series and IBM-PC and instruction manual. Elsevier-Biosoft, Elsevier Science Publishers, Cambridge, U.K. 1985, 19-28.
60. 60 Sheldrick, G.M. (1986).SHELXS86. Program for the solution of crystal structures. Univ. of Göttingen, Germany
61. 61 Sheldrick, G. M. (1976). SHELX76. Program for crystal structure determination. Univ. of Cambridge, England